“Bimekizumab Long-Term On-Treatment Remission and Associated Sustained Improvements in Quality of Life in Moderate to Severe Plaque Psoriasis Across Five Phase 3 3b Trials”. SKIN The Journal of Cutaneous Medicine, vol. 10, no. 3, May 2026, p. s772, https://doi.org/10.25251/pkdcct35.